Further exploring the signaling pathways in tumors, ssGSEA analysis showed that while SLC7A1 was highly expressed in patients with serous ovarian cancer, TGF‐β and EMT pathways were significantly enriched (p < 0.05) (Figure 4D). Here, SLC7A1 is linked to ovarian serous adenocarcinoma.